UA81797C2 - Лекарственная форма тенофовира дизопроксил фумарата и эмтрицитабина для комбинированной антивирусной терапии - Google Patents
Лекарственная форма тенофовира дизопроксил фумарата и эмтрицитабина для комбинированной антивирусной терапии Download PDFInfo
- Publication number
- UA81797C2 UA81797C2 UAA200507947A UA2005007947A UA81797C2 UA 81797 C2 UA81797 C2 UA 81797C2 UA A200507947 A UAA200507947 A UA A200507947A UA 2005007947 A UA2005007947 A UA 2005007947A UA 81797 C2 UA81797 C2 UA 81797C2
- Authority
- UA
- Ukraine
- Prior art keywords
- emtricitabine
- tenofovir
- disoproxil fumarate
- tenofovir disoproxil
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44024603P | 2003-01-14 | 2003-01-14 | |
| PCT/US2004/000832 WO2004064845A1 (en) | 2003-01-14 | 2004-01-13 | Compositions and methods for combination antiviral therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA81797C2 true UA81797C2 (ru) | 2008-02-11 |
Family
ID=39817204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200507947A UA81797C2 (ru) | 2003-01-14 | 2004-01-13 | Лекарственная форма тенофовира дизопроксил фумарата и эмтрицитабина для комбинированной антивирусной терапии |
Country Status (4)
| Country | Link |
|---|---|
| AR (2) | AR040805A1 (ru) |
| NO (1) | NO20160777A1 (ru) |
| TW (1) | TWI355270B (ru) |
| UA (1) | UA81797C2 (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2665037C2 (ru) * | 2016-12-12 | 2018-08-27 | Общество с ограниченной ответственностью "Вириом" | Изопропил N-[{ [(1R)-2-(6-амино-9H-пурин-9-ил)-1-метилэтокси]метил} (1,3-бензотиазол-6-ил-окси)фосфорил]-L-аланинат фумарат в качестве противовирусного препарата - пролекарства Тенофовира |
-
2004
- 2004-01-13 UA UAA200507947A patent/UA81797C2/ru unknown
- 2004-01-13 TW TW093100813A patent/TWI355270B/zh active
- 2004-01-14 AR AR20040100087A patent/AR040805A1/es not_active Application Discontinuation
-
2015
- 2015-08-24 AR ARP150102708A patent/AR101679A2/es unknown
-
2016
- 2016-05-09 NO NO20160777A patent/NO20160777A1/no not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2665037C2 (ru) * | 2016-12-12 | 2018-08-27 | Общество с ограниченной ответственностью "Вириом" | Изопропил N-[{ [(1R)-2-(6-амино-9H-пурин-9-ил)-1-метилэтокси]метил} (1,3-бензотиазол-6-ил-окси)фосфорил]-L-аланинат фумарат в качестве противовирусного препарата - пролекарства Тенофовира |
Also Published As
| Publication number | Publication date |
|---|---|
| AR101679A2 (es) | 2017-01-04 |
| TWI355270B (en) | 2012-01-01 |
| TW200423946A (en) | 2004-11-16 |
| NO20160777A1 (no) | 2005-10-13 |
| AR040805A1 (es) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2004206821C1 (en) | Compositions and methods for combination antiviral therapy | |
| UA81797C2 (ru) | Лекарственная форма тенофовира дизопроксил фумарата и эмтрицитабина для комбинированной антивирусной терапии | |
| AU2011253996B2 (en) | Compositions and methods for combination antiviral therapy | |
| HK1224587A1 (en) | Compositions and methods for combination antiviral therapy | |
| HK1119590A (en) | Compositions and methods for combination antiviral therapy | |
| HK1229687A1 (en) | Compositions and methods for combination antiviral therapy | |
| AU2014216017A1 (en) | Compositions and methods for combination antiviral therapy |